ASXL3 and small cell lung carcinoma: However, we observed a similar trend but with less of a difference in cell viability between ASXL3-high and ASXL3-low SCLC cells with other BET inhibitors, such as JQ1 and iBET151 (Additional file 2: Figure S6D and S6E).